Navigation Links
Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

e mouth, the salivary glands and inside the throat, the voice box, eye and orbit, thyroid and the lymph nodes in the upper neck. In addition, it is estimated that more than 12,900 Americans will die from this disease this year. Head and neck cancer most often affects people over the age of 50, and men are twice as likely to be diagnosed as women. The most common risk factors are tobacco and excessive alcohol use.

About ERBITUX(R) (Cetuximab)

ERBITUX is a monoclonal antibody (IgG1 Mab) designed to inhibit the function of a molecular structure expressed on the surface of normal and tumor cells called the epidermal growth factor receptor (EGFR, HER1, c-ErbB-1). In vitro assays and in vivo animal studies have shown that binding of ERBITUX to the EGFR blocks phosphorylation and activation of receptor-associated kinases, resulting in inhibition of cell growth, induction of apoptosis, and decreased matrix metalloproteinase and vascular endothelial growth factor production. In vitro, ERBITUX can mediate antibody-dependent cellular cytotoxicity (ADCC) against certain human tumor types. While the mechanism of ERBITUX' anti-tumor effect(s) in vivo is unknown, all of these processes may contribute to the overall therapeutic effect of ERBITUX. EGFR is part of a signaling pathway that is linked to the growth and development of many human cancers, including those of the head and neck, colon and rectum.

ERBITUX (Cetuximab), in combination with radiation therapy, is indicated for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck. ERBITUX as a single agent is indicated for the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck for whom prior platinum-based therapy has failed.

ERBITUX is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma (mCRC) in combination with irinotecan for patients who are refractory to irinotecan-based chemotherapy, an
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
(Date:3/3/2015)... , March 3, 2015 Although lung ... the world, there are only 18 drugs in the ... Almita and Avastin are nearing their patent expiry in ... therapeutics market offers vast potential that drug manufacturers are ... treatment of small cell lung cancer (SCLC) and non-small ...
(Date:3/3/2015)... , March 3, 2015 ImmunoCellular Therapeutics, ... Andrew Gengos , Chief Executive Officer of ImmunoCellular, will ... 27 th Annual ROTH Conference on Tuesday, March ... Hotel, Laguna Niguel , CA.   ... the ROTH presentation, please log on through a link ...
(Date:3/3/2015)... , March 3, 2015 Chrono Therapeutics ... an investment by Rock Health , the leading ... of Chrono,s SmartStop™ programmable transdermal drug delivery system and ... Smoking kills more than 500,000 Americans each year, ... in the United States . Of ...
Breaking Medicine Technology:Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 3
... N.J., Sept. 28 Laureate Pharma, Inc., ... company, today announced the appointment of Steven ... Mr. Johnson will be responsible for Laureate,s ... business development and project management, supporting the ...
... JUNCTION, N.J., Sept. 28 Tamir Biotechnology, Inc. ... Corporation) announced today that scientists supported by the ... reported test results confirming two of our lead ... cell culture and plaque reduction assay (the gold ...
Cached Medicine Technology:Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development 2New Discovery Targets Cytomegalovirus (CMV) 2New Discovery Targets Cytomegalovirus (CMV) 3New Discovery Targets Cytomegalovirus (CMV) 4
(Date:3/3/2015)... (PRWEB) March 03, 2015 United Benefit ... organization, is pleased to welcome The Gehring Group, Inc. ... consulting services for more than 20 years, The Gehring ... benefits and risk management consulting firm that serves organizations ... and risk management programs. , Based in ...
(Date:3/3/2015)... Grants Pass, OR (PRWEB) March 03, 2015 ... and stroke severity* confirms what water advocate and radio ... believes that dehydration – lack of sufficient water in ... affect as much as 90 percent of the US ... that dehydration is a factor in nearly all disease, ...
(Date:3/3/2015)... Everett, WA (PRWEB) March 03, 2015 ... dedication to a lifestyle of fitness and exercise. Community ... an article presenting 6 ways that families in ... fit during the winter months. , CHC says, ... for grilled chicken and steamed veggies, many families wonder ...
(Date:3/3/2015)... 2015 Prophecy Healthcare®, Inc., the ... care testing, is now conducting dedicated research to ... result of acquiring the exam rights and Intellectual ... 2014, the research will soon create more health ... providers, healthcare staffing organizations and more. ...
(Date:3/3/2015)... 03, 2015 Extend Nutrition, a leading nutritional ... amount of calories consumed at the next meal by an ... There are no lifestyle changes needed and no program to ... day. , The starter kit contains 60 servings of nutritional ... of protein, fiber, healthy fat and complex carbohydrates that helps ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 2Health News:Study linking dehydration and stroke severity supports fresh water advocate’s warnings 3Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 2Health News:Prophecy Healthcare Acquires IP to Expand Behavioral Benchmarks 3Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3
... Drug Administration (FDA) have approved a virus mix in spray ... given last month.// , ,Processed meats after being ... is a combination of viruses that kill this bacteria. Food ... and distribution. ,This virus mix is not effective ...
... crisp habit is prevalent among 55% of the British children and ... ,The BHF started a campaign to create awareness among ... common foods and the figures were releases as a part of ... oil, salt and sugar as we and our children continue to ...
... actors, echoed The Bard, eons ago. As the curtains go ... today on// World Alzheimer’s day, the stage is set for deep ... and evolve better strategies for effective management of the disease. ... nervous system marked by stark and untimely backslide in the patient’s ...
... biological markers that can predict disability, morbidity and ... researchers// analyzed 13 biomarkers representing neuroendocrine and vascular ... years in 1,189 high-functioning men and women aged ... Aging. The goals were to identify biomarker combinations ...
... over plans of British hospitals to outsource medical transcription to ... are not shelved.// ,Several hospitals in Britain have outsourced ... typing up patients' notes to India to save costs at ... hospitals in Staffordshire, Leeds and Cornwall. ,At the ...
... reported having updated the warning label on the Ortho ... of blood clots from it.// ,The drug manufacturer ... faced two times the risk of clots in the ... pills. ,Another study commissioned by Johnson and Johnson, ...
Cached Medicine News:Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 2Health News:World Alzheimer’s Day: In Memory of Those With 'Memory Loss 3Health News:Britain Hospital Staff Threatens Strike 2Health News:Contraceptive Patch Carries Risk of Blood clots 2
... automated patient ID verification and laboratory specimen labeling ... of the phlebotomist or nurse, the identity of ... proper verification is made, a bar coded sample ... Its unique design simplifies and eliminates the interface ...
... Bridge™ Specimen Collections, a Cerner ... for specimen identification and collection. The ... of the specimen collections process by ... and clinical information system integration to ...
... bar-code medication administration solution that safely automates ... bar-code technology. Caregivers use a wireless bar-code ... to verify that the right patient receives ... in the right dosage via the right ...
... Korchek Technologies CareChek ... employs barcode technology, Windows ... with integrated scanners (to ... at the bedside) and ...
Medicine Products: